Hazha Hassan Tahir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hazha Hassan Tahir has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Amirreza Gholami
Department of Chemistry Dalhousie University Halifax Nova Scotia Canada
1 shared publication Ammar Alfergah
Department of Food Science and Nutrition Faculty of Agriculture and Food Ibb University Ibb City Yemen ibb-univ.net
1 shared publication- Azad Mohammed Aziz Ahmed
Nursing Department, Darbandikhan Technical Institute Sulaimani Polytechnic University Sulaimani Kurdistan Region Iraq
1 shared publication - Hamza Kamaran Hama
Department of Special Education, Sharazur Educational College University of Halabja Halabja Iraq
1 shared publication - Kawther Hoshear Faiq
Department of Medical Laboratory Science Halabja Technical College Sulaimani Polytechnic University Sulaymaniyah Iraq spu.edu.iq
1 shared publication - Mohammed Ali Hama
Department of Clinical Biochemistry, College of Science University of Halabja Halabja Iraq
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 2763026
Campylobacter jejuni Across the Food Chain: Integrating Pathogenesis, Persistence, Antimicrobial Resistance, and Emerging One Health Control Strategies
Campylobacter jejuni continues to be a globally important foodborne pathogen and is one of the most common bacterial causes of gastroenteritis in humans. This fastidious microaerophilic organism is seldom cultured outside of animal hosts, yet it repeatedly populates poultry, livestock, water, processing environments, retail foods, domestic kitchens, and humans. Here, we critically integrate the evidence in a transmission‐connected, farm‐to‐fork pathway spanning colonization of animal reservoirs and carcass contamination to environmental persistence, human exposure, and disease (including antimicrobial resistance), detection, and intervention. In many systems, asymptomatic, high‐density colonization of poultry is the main amplification reservoir and carcass cross‐contamination, mixed‐species biofilms, aerotolerance, oxidative‐stress defense, cold survival, and viable‐but‐nonculturable cells support persistence through processing and distribution. Coordinated motility, chemotaxis, adhesion, disruption of epithelial barrier functions, invasion, and cytolethal distending toxin activity contribute to epithelial injury and inflammation, whereas lipooligosaccharide‐mediated molecular mimicry contributes to postinfectious complications. Factors such as persistent target‐site mutations, CmeABC efflux, acquired determinants, and antimicrobial selection within One Health compartments continue to sustain resistance to fluoroquinolones, tetracyclines, and macrolides in certain settings. Because no single point intervention can sufficiently control transmission across the food chain, effective risk reduction relies on a portfolio of components such as whole‐farm biosecurity, biological control, hygienic processing and handling, cold‐chain management, consumer hygiene interventions at home, antimicrobial stewardship, viability‐sensitive detection and genomic surveillance. These findings are consistent with multihurdle control strategies and integrated One Health surveillance linking both animal, food, environmental, and human health sectors. Consequently, future policy and research initiatives should ideally focus on harmonized sampling and surveillance protocols, standardized outcomes of intervention studies, validation at the commercial scale and evidence directly relating C. jejuni reductions to risk of human disease.
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 2763026
Open AccessCampylobacter jejuni Across the Food Chain: Integrating Pathogenesis, Persistence, Antimicrobial Resistance, and Emerging One Health Control Strategies
Campylobacter jejuni continues to be a globally important foodborne pathogen and is one of the most common bacterial causes of gastroenteritis in humans. This fastidious microaerophilic organism is seldom cultured outside of animal hosts, yet it repeatedly populates poultry, livestock, water, processing environments, retail foods, domestic kitchens, and humans. Here, we critically integrate the evidence in a transmission‐connected, farm‐to‐fork pathway spanning colonization of animal reservoirs and carcass contamination to environmental persistence, human exposure, and disease (including antimicrobial resistance), detection, and intervention. In many systems, asymptomatic, high‐density colonization of poultry is the main amplification reservoir and carcass cross‐contamination, mixed‐species biofilms, aerotolerance, oxidative‐stress defense, cold survival, and viable‐but‐nonculturable cells support persistence through processing and distribution. Coordinated motility, chemotaxis, adhesion, disruption of epithelial barrier functions, invasion, and cytolethal distending toxin activity contribute to epithelial injury and inflammation, whereas lipooligosaccharide‐mediated molecular mimicry contributes to postinfectious complications. Factors such as persistent target‐site mutations, CmeABC efflux, acquired determinants, and antimicrobial selection within One Health compartments continue to sustain resistance to fluoroquinolones, tetracyclines, and macrolides in certain settings. Because no single point intervention can sufficiently control transmission across the food chain, effective risk reduction relies on a portfolio of components such as whole‐farm biosecurity, biological control, hygienic processing and handling, cold‐chain management, consumer hygiene interventions at home, antimicrobial stewardship, viability‐sensitive detection and genomic surveillance. These findings are consistent with multihurdle control strategies and integrated One Health surveillance linking both animal, food, environmental, and human health sectors. Consequently, future policy and research initiatives should ideally focus on harmonized sampling and surveillance protocols, standardized outcomes of intervention studies, validation at the commercial scale and evidence directly relating C. jejuni reductions to risk of human disease.